https://scholars.lib.ntu.edu.tw/handle/123456789/641513
Title: | CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer | Authors: | Jänne, Pasi A Planchard, David Kobayashi, Kunihiko Cheng, Ying Lee, Chee Khoon Valdiviezo, Natalia Laktionov, Konstantin Yang, Tsung-Ying Yu, Yan Kato, Terufumi Jiang, Liyan Chewaskulyong, Busyamas Lucien Geater, Sarayut Maurel, Jean-Marc Rojas, Carlos Takahashi, Toshiaki Havel, Libor Shepherd, Frances A Tanaka, Kentaro Ghiorghiu, Dana Amin, Neha P Armenteros-Monterroso, Elena Huang, Xiangning Chaudhry, Ammar Ahmed CHIH-HSIN YANG |
Issue Date: | 1-Mar-2024 | Journal Volume: | 42 | Journal Issue: | 7 | Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Abstract: | We report CNS efficacy of first-line osimertinib plus chemotherapy versus osimertinib monotherapy in patients with epidermal growth factor receptor (EGFR)-mutated advanced non-small-cell lung cancer (NSCLC) from the phase III FLAURA2 study according to baseline CNS metastasis status. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/641513 | ISSN: | 0732183X | DOI: | 10.1200/JCO.23.02219 |
Appears in Collections: | 腫瘤醫學研究所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.